Tissue-specific expression pattern of estrogen receptors (ER):: Quantification of ERα and ERβ mRNA with real-time RT-PCR

被引:121
作者
Pfaffl, MW [1 ]
Lange, IG [1 ]
Daxenberger, A [1 ]
Meyer, HHD [1 ]
机构
[1] Tech Univ Munich, Ctr Life & Food Sci, Res Ctr Milk & Food Weihenstephan, Inst Physiol, D-85380 Freising Weihenstephan, Germany
关键词
ER alpha; ER beta; expression pattern; real-time RT-PCR; estrogen treatment;
D O I
10.1034/j.1600-0463.2001.090503.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have examined the tissue-specific mRNA expression of ERa and ERP in various bovine tissues using real-time RT-PCR. The goal of this study was to evaluate the deviating tissue sensitivities and the influence of the estrogenic active preparation RALGRO on the tissue-specific expression and regulation of both ER subtypes. RALCRO contains Zeranol (alpha -Zearalanol), a derivative of the mycotoxin Zearalenon, shows strong estrogenic and anabolic effects, and exhibits all symptoms of hyperestrogenism, in particular reproductive and developmental disorders. Eight heifers were treated over 8 weeks with multiple-dose implantations (0x, 1x, 3x, 10x) of Zeranol. Plasma Zeranol concentration, measured by enzyme immunoassay, of multiple treated heifers was elevated. To quantify ERa and ERP transcripts also in low-abundant tissues, sensitive and reliable real-time RT-PCR quantification methods were developed and validated on the LightCycler. Expression results indicate the existence of both ER subtypes in all 15 investigated tissues. All tissues exhibited a specific ERa and ERP expression pattern and regulation. With increasing Zeranol concentrations, a significant downregulation of ERa mRNA expression could be observed in jejunum (p <0.001) and kidney medulla (p <0.05). These data support the hypothesis that ERP may have different biological functions than ERa, especially in kidney and jejunum.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 39 条
[1]  
ARJANDI BH, 1993, BONE MINER, V21, P63
[2]   Fish model for assessing the in vivo estrogenic potency of the mycotoxin zearalenone and its metabolites [J].
Arukwe, A ;
Grotmol, T ;
Haugen, TB ;
Knudsen, FR ;
Goksoyr, A .
SCIENCE OF THE TOTAL ENVIRONMENT, 1999, 236 (1-3) :153-161
[3]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[4]   Estrogen receptor-beta mRNA expression in rat ovary: Down-regulation by gonadotropins [J].
Byers, M ;
Kuiper, GGJM ;
Gustafsson, JA ;
ParkSarge, OK .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (02) :172-182
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]   Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse [J].
Couse, JF ;
Lindzey, J ;
Grandien, K ;
Gustafsson, JA ;
Korach, KS .
ENDOCRINOLOGY, 1997, 138 (11) :4613-4621
[7]   Ovarian estrogen receptor α and β mRNA expression:: impact of development and estrogen [J].
Drummond, AE ;
Baillie, AJ ;
Findlay, JK .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 149 (1-2) :153-161
[8]  
DUCHATEL JP, 1985, ANN RECH VET, V16, P93
[9]   Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern [J].
Enmark, E ;
Pelto-Huikko, M ;
Grandien, K ;
Lagercrantz, S ;
Lagercrantz, J ;
Fried, G ;
Nordenskjöld, M ;
Gustafsson, JÅ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4258-4265
[10]   Expression of estrogen receptor-β protein in rodent ovary [J].
Fitzpatrick, SL ;
Funkhouser, JM ;
Sindoni, DM ;
Stevis, PE ;
Deecher, DC ;
Bapat, AR ;
Merchenthaler, I ;
Frail, DE .
ENDOCRINOLOGY, 1999, 140 (06) :2581-2591